A new microchip invented by Scripps Research scientists can reveal how a person's antibodies interact with viruses—using just ...

Some antibodies neutralize the virus effectively, while others bind only weakly. Pinpointing exactly which parts of a virus ...

Approximately 40% of the European population are allergic to pollen, and their symptoms cause an estimated loss of 100 ...

Super Agers author Eric Topol unpacks the rise of biological age tests—from organ clocks to immune system clocks—and how they might revolutionize early diagnosis of disease ...

For the second time this year, Leo Pharma has struck a partnership with a major drugmaker, this time paying Boehringer ...

HXN-1001 is a half-life extended next-generation anti-TL1A antibody with great potential for the treatment of patients with inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn's ...

Sarilumab treatment with a rapid glucocorticoid taper in relapsing polymyalgia rheumatica shows greater improvements in ...

U.S. and Chinese researchers appear to have unlocked a novel way to stop T cells from attacking the body in MS and other ...

Jasper Therapeutics is halving its workforce as part of cost-cutting measures aimed at extending the clinical-stage biotechnology company's runway on the heels of a clinical setback with its lead drug ...

Broadens global development program for verekitug into third indication, strengthening pipeline across severe respiratory diseases including chronic rhinosinusitis with nasal polyps (CRSwNP), severe ...

The team is "here to stay," no matter what, lead researcher Keith Bowers said, amid federal funding changes for scientific ...